tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

22nd Century Settles Insurance Litigation for $9.5M

Story Highlights
22nd Century Settles Insurance Litigation for $9.5M

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

22nd Century ( (XXII) ) has shared an announcement.

On September 18, 2025, 22nd Century Group, Inc. settled its litigation with its insurer regarding the November 2022 fire at its Grass Valley manufacturing facility, resulting in a $9.5 million cash payment. This settlement allows the company to transition from survival capital to growth capital, positioning it to focus on profitability by 2026 and expand distribution for its branded products.

The most recent analyst rating on (XXII) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on 22nd Century stock, see the XXII Stock Forecast page.

Spark’s Take on XXII Stock

According to Spark, TipRanks’ AI Analyst, XXII is a Underperform.

22nd Century’s overall stock score is primarily impacted by its weak financial performance, characterized by negative margins, high leverage, and cash flow challenges. Technical analysis also indicates a bearish trend, further weighing on the score. While there are strategic shifts and corporate developments that could improve future prospects, the current financial and market conditions present significant risks.

To see Spark’s full report on XXII stock, click here.

More about 22nd Century

22nd Century Group, Inc. is a pioneering company in the tobacco harm reduction industry, focusing on developing proprietary non-GMO reduced nicotine tobacco plants. Their flagship product, the VLN® cigarette, contains 95% less nicotine than traditional cigarettes and is the only low nicotine combustible cigarette authorized by the FDA in the United States.

Average Trading Volume: 1,636,353

Technical Sentiment Signal: Strong Sell

Current Market Cap: $5.71M

See more data about XXII stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1